Secreted protein acidic and rich in cysteines-like 1 suppresses aggressiveness and predicts better survival in colorectal cancers

Clinical Cancer Research

Volumn 18, Issue 19, 2012, Pages 5438-5448

  Hu, Hanguang ^a   Zhang, Hang ^a   Ge, Weiting ^a   Liu, Xiyong ^b   Loera, Sofia ^b   Chu, Peiguo ^b   Chen, Huarong ^a   Peng, Jiaping ^a   Zhou, Lun ^a   Yu, Shujing ^a   Yuan, Ying ^a   Zhang, Suzhan ^a   Lai, Lily ^b   Yen, Yun ^b   Zheng, Shu ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN; SCATTER FACTOR RECEPTOR; SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE LIKE 1; UNCLASSIFIED DRUG;

ADULT; AGED; ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER INVASION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; COLON ADENOCARCINOMA; COLORECTAL CANCER; COLORECTAL SURGERY; CONTROLLED STUDY; DISEASE ASSOCIATION; DISTANT METASTASIS; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENETIC TRANSFECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POPULATION RESEARCH; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INDUCTION; RECTUM CARCINOMA; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECRETED PROTEIN ACIDIC AND RICH IN CYSTEINE LIKE 1 GENE; SIGNAL TRANSDUCTION; SURVIVAL PREDICTION; TUMOR DIFFERENTIATION; TUMOR SUPPRESSOR GENE; TUMOR XENOGRAFT; WESTERN BLOTTING;

ANIMALS; CALCIUM-BINDING PROTEINS; CELL LINE, TUMOR; CELL MOVEMENT; COLORECTAL NEOPLASMS; EPITHELIAL-MESENCHYMAL TRANSITION; EXTRACELLULAR MATRIX PROTEINS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; MICE; MICE, NUDE; NEOPLASM INVASIVENESS; PROPORTIONAL HAZARDS MODELS; TRANSPLANTATION, HETEROLOGOUS;

EID: 84866918740     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-0124     Document Type: Article

References (35)

1. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011;61:212-36.
2. Rim SH, Seeff L, Ahmed F, King JB, Coughlin SS. Colorectal cancer incidence in the United States, 1999-2004: an updated analysis of data from the National Program of Cancer Registries and the Surveillance, Epidemiology, and End Results Program. Cancer 2009;115:1967-76.
3. Hawk ET, Limburg PJ, Viner JL. Epidemiology and prevention of colorectal cancer. Surg Clin North Am 2002;82:905-41. (Pubitemid 35463075)
4. Jaeck D, Bachellier P, Guiguet M, Boudjema K, Vaillant JC, Balladur P, et al. Long-term survival following resection of colorectal hepatic metastases. Association Francaise de Chirurgie. Br J Surg 1997;84:977-80. (Pubitemid 27310867)
5. Bendik I, Schraml P, Ludwig CU. Characterization of MAST9/Hevin, a SPARC-like protein, that is down-regulated in non-small cell lung cancer. Cancer Res 1998;58:626-9. (Pubitemid 28099469)
6. Girard JP, Springer TA. Cloning from purified high endothelial venule cells of hevin, a close relative of the antiadhesive extracellular matrix protein SPARC. Immunity 1995;2:113-23.
7. Girard JP, Springer TA. Modulation of endothelial cell adhesion by hevin, an acidic protein associated with high endothelial venules. J Biol Chem 1996;271:4511-7. (Pubitemid 26074151)
8. Claeskens A, Ongenae N, Neefs JM, Cheyns P, Kaijen P, Cools M, et al. Hevin is down-regulated in many cancers and is a negative regulator of cell growth and proliferation. Br J Cancer 2000;82:1123-30. (Pubitemid 30128867)
9. Maak S, Jaesert S, Neumann K, Yerle M, von Lengerken G. Isolation of expressed sequence tags of skeletal muscle of neonatal healthy and splay leg piglets and mapping by somatic cell hybrid analysis. Anim Genet 2001;32:303-7. (Pubitemid 33011524)
10. Oritani K, Kincade PW. Lymphopoiesis and matrix glycoprotein SC1/ECM2. Leuk Lymphoma 1998;32:1-7. (Pubitemid 29086378)
11. Soderling JA, Reed MJ, Corsa A, Sage EH. Cloning and expression of murine SC1, a gene product homologous to SPARC. J Histochem Cytochem 1997;45:823-35.
12. Johnston IG, Paladino T, Gurd JW, Brown IR. Molecular cloning of SC1: a putative brain extracellular matrix glycoprotein showing partial similarity to osteonectin/BM40/SPARC. Neuron 1990;4:165-76. (Pubitemid 20149764)
13. Girard JP, Baekkevold ES, Yamanaka T, Haraldsen G, Brandtzaeg P, Amalric F. Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization. Am J Pathol 1999;155:2043-55.
14. Isler SG, Schenk S, Bendik I, Schraml P, Novotna H, Moch H, et al. Genomic organization and chromosomal mapping of SPARC-like 1, a gene down regulated in cancers. Int J Oncol 2001;18:521-6.
15. Lau CP, Poon RT, Cheung ST, Yu WC, Fan ST. SPARC and Hevin expression correlate with tumour angiogenesis in hepatocellular carcinoma. J Pathol 2006;210:459-68. (Pubitemid 44830606)
16. Nelson PS, Plymate SR, Wang K, True LD, Ware JL, Gan L, et al. Hevin, an antiadhesive extracellular matrix protein, is down-regulated in metastatic prostate adenocarcinoma. Cancer Res 1998;58:232-6. (Pubitemid 28047060)
17. Notterman DA, Alon U, Sierk AJ, Levine AJ. Transcriptional gene expression profiles of colorectal adenoma, adenocarcinoma, and normal tissue examined by oligonucleotide arrays. Cancer Res 2001;61:3124-30. (Pubitemid 32691964)
18. Yu SJ, Yu JK, Ge WT, Hu HG, Yuan Y, Zheng S. SPARCL1, Shp2, MSH2, E-cadherin, p53, ADCY-2 and MAPK are prognosis-related in colorectal cancer. World J Gastroenterol 2011;17:2028-36.
19. Zhang H, Widegren E, Wang DW, Sun XF. SPARCL1: a potential molecule associated with tumor diagnosis, progression and prognosis of colorectal cancer. Tumour Biol 2011;32:1225-31.
20. Gasparini G, Harris AL. Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool. J Clin Oncol 1995;13:765-82.
21. Meng PQ, Hou G, Zhou GY, Peng JP, Dong Q, Zheng S. Application of new tissue microarrayer-ZM-1 without recipient paraffin block. J Zhejiang Univ Sci B 2005;6:853-8.
22. Esposito I, Kayed H, Keleg S, Giese T, Sage EH, Schirmacher P, et al. Tumor-suppressor function of SPARC-like protein 1/Hevin in pancreatic cancer. Neoplasia 2007;9:8-17. (Pubitemid 46203930)
23. Primrose JN. Surgery for colorectal liver metastases. Br J Cancer 2010;102:1313-8.
24. Kucukdereli H, Allen NJ, Lee AT, Feng A, Ozlu MI, Conatser LM, et al. Control of excitatory CNS synaptogenesis by astrocyte-secreted proteins Hevin and SPARC. Proc Natl Acad Sci U S A 2011;108:E440-9.
25. Weaver MS, Workman G, Cardo-Vila M, Arap W, Pasqualini R, Sage EH. Processing of the matricellular protein hevin in mouse brain is dependent on ADAMTS4. J Biol Chem 2010;285:5868-77.
26. Weimer JM, Stanco A, Cheng JG, Vargo AC, Voora S, Anton ES. ABAC transgenic mouse model to analyze the function of astroglial SPARCL1 (SC1) in the central nervous system. Glia 2008;56:935-41.
27. Thiery JP. Epithelial-mesenchymal transitions in development and pathologies. Curr Opin Cell Biol 2003;15:740-6. (Pubitemid 37487967)
28. Baum B, Settleman J, Quinlan MP. Transitions between epithelial and mesenchymal states in development and disease. Semin Cell Dev Biol 2008;19:294-308.
29. Kikuchi R, Sonobe M, Kobayashi M, Ishikawa M, Kitamura J, Nakayama E, et al. Expression of IGF1R is associated with tumor differentiation and survival in patients with lung adenocarcinoma. Ann Surg Oncol 2012;19 Suppl 3:412-20.
30. Lachat P, Shaw P, Gebhard S, van Belzen N, Chaubert P, Bosman FT. Expression ofNDRG1, a differentiation-related gene, in human tissues. Histochem Cell Biol 2002;118:399-408. (Pubitemid 35352125)
31. Abdelmagid SM, Barbe MF, Rico MC, Salihoglu S, Arango-Hisijara I, Selim AH, et al. Osteoactivin, an anabolic factor that regulates osteoblast differentiation and function. Exp Cell Res 2008;314:2334-51.
32. Arosarena OA, Del Carpio-Cano FE, Dela Cadena RA, Rico MC, Nwodim E, Safadi FF. Comparison of bone morphogenetic protein-2 and osteoactivin for mesenchymal cell differentiation: effects of bolus and continuous administration. J Cell Physiol 2011;226:2943-52.
33. Fotovati A, Abu-Ali S, Sugita Y, Nakamura Y. Expression of N-myc downstream regulated gene 1 (NDRG1) in central neurocytoma. J Clin Neurosci 2011;18:1383-5.
34. Fotovati A, Abu-Ali S, Kage M, Shirouzu K, Yamana H, Kuwano M. Nmyc downstream-regulated gene 1 (NDRG1) a differentiation marker of human breast cancer. Pathol Oncol Res 2011;17:525-33.
35. Strzelczyk B, Szulc A, Rzepko R, Kitowska A, Skokowski J, Szutowicz A, et al. Identification of high-risk stage II colorectal tumors by combined analysis of the NDRG1 gene expression and the depth of tumor invasion. Ann Surg Oncol 2009;16:1287-94.